However, NCGS 116-255 states that the Collaboratory: As per Section 8.12 of Session Law 2021-180, the Academic Research Partner is defined as any institution of higher education in North Carolina. Are only UNC System campuses allowed to apply? No. Any potential conflicts of interest pertaining to financial relationships among team members MUST be disclosed in the Project Team template provided in the application package. No reporting, managerial, financial or supervisory relationship may exist between the two principal investigators. Each partner must identify a separate principal investigator. Can the same individual serve as the principal investigator of both the Business Partner and Academic Research Partner? No. There are no limitations on the number of Academic Research Partner teams at any given institution of higher education within North Carolina. is each university only allowed to participate in one proposal)? No. Is this a limited submission opportunity for universities (i.e. Only one application may be submitted by each Business Partner principal investigator. Can applicants submit more than one application? No.
See application instructions for guidance on submission. Who should submit the application? The individual serving as principal investigator for the Business Partner must submit the application to the Collaboratory on behalf of both partners. Both the Business Partner and Academic Research Partner must identify separate, independent principal investigators.
#COLLABORATORY PROJECT FULL#
Any questions not covered in this section should be directed to Who is eligible to apply? Applications will only be accepted from a Business Partner working with an Academic Research Partner, both of which must meet specific criteria listed in the full application instructions. This section will be updated during the open call for proposals. This broad solicitation is intended to help businesses and academic research partners work together to propose innovative, collaborative projects that can transform applied research and innovation into technological solutions for the benefit of public health and the economy in North Carolina. This program does not have any priority areas beyond the need to support business-academic partnerships that seek to develop new, or apply existing, technology for monitoring, assessing, and addressing the public health and/or economic impacts of COVID-19. Instead, a department-level signature is sufficient. For the cover page, the signature of an Authorized Organizational Representative is not mandatory for UNC-Chapel Hill applicants.If a university-business agreement describing intellectual property and data sharing cannot be signed before the submission deadline, applicants may submit a letter of intent instead – please see pages 4-6 of the application instructions PDF.It is anticipated that the results from this study will impact on the eventual prevention, cure and treatment of MS.The application instructions and application templates provided below have been corrected as follows: The study is designed to (i) increase the database for genetic epidemiological/molecular genetic research and (ii) gather population-based data to further our understanding of the non-genetic factors in the etiology of MS. The CCPGSMS-Phase 2 is in progress so specific results are not available. This national effort is coordinated by the MS Clinics in Vancouver and London. Blood samples are taken for molecular genetic studies.
#COLLABORATORY PROJECT SERIES#
A series of structured questionnaires is administered to MS index cases, spouse controls and mothers of index cases and spouse controls (if available) by trained interviewers.
The CCPGSMS-Phase 2 is a nation-wide collaborative effort involving all the 15 Canadian MS clinics. The present paper describes the rationale and methodology for the CCPGSMS-Phase 2. Results from the Canadian Collaborative Project on Genetic Susceptibility to Multiple Sclerosis (MS)-Phase 1 (CCPGSMS-Phase 1) together with other family data published since 1982 have led to the following conclusions about the etiology of MS: (i) genetic and non-genetic (environmental) factors are involved in the etiology of MS on a population basis (ii) the familial aggregation of MS is genetic (iii) maternal factors do not influence the risk for siblings to develop MS and (iv) MS appears to be oligogenic.
0 kommentar(er)
